Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years.

about

Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years.

Item

http://www.wikidata.org/entity/Q49716886

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years.

@en

Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years.

@nl

type

Item

label

Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years.

@en

Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years.

@nl

prefLabel

Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years.

@en

Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years.

@nl

P1476

Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years

@en

P2093

Aaron D Falchook

http://www.w3.org/2001/XMLSchema#string

Fang Tian

http://www.w3.org/2001/XMLSchema#string

Nandini Selvam

http://www.w3.org/2001/XMLSchema#string

Ronald C Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Patients' expectations about effects of chemotherapy for advanced cancer

Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.

Cancer statistics, 2015

A modified poisson regression approach to prospective studies with binary data

Novel Data Sharing Between a Comprehensive Cancer Center and a Private Payer to Better Understand Care at the End of Life.

Physicians' propensity to discuss prognosis is associated with patients' awareness of prognosis for metastatic cancers.

Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.

Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.

American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.

Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.

P31

scholarly article

P356

10.1093/JNCI/DJX028

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Stacie B. Dusetzina

Ramsankar Basak

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28954284

http://www.w3.org/2001/XMLSchema#string

P932

6440271

http://www.w3.org/2001/XMLSchema#string